223 related articles for article (PubMed ID: 9685998)
1. [False positive scintigraphic images in the surveillance of differentiated thyroid cancers].
Rudoni S; Toubeau M; Mansuy S; Vaillant G; Verges B; Brun JM; Brunotte F
Ann Endocrinol (Paris); 1997; 58(5):399-407. PubMed ID: 9685998
[TBL] [Abstract][Full Text] [Related]
2. [The correlation between serum thyroglobulin and iodine-131 scanning in detecting metastases in patients with a differentiated thyroid carcinoma].
Abduluakhab M; Gavrilov M; Mladenov B
Khirurgiia (Sofiia); 1997; 50(4):33-6. PubMed ID: 9739856
[TBL] [Abstract][Full Text] [Related]
3. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
4. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
Gerard SK; Dam HQ
Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
[No Abstract] [Full Text] [Related]
5. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.
Wang W; Macapinlac H; Larson SM; Yeh SD; Akhurst T; Finn RD; Rosai J; Robbins RJ
J Clin Endocrinol Metab; 1999 Jul; 84(7):2291-302. PubMed ID: 10404792
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-MIBI in differentiated thyroid carcinoma.
Roelants V; Beckers C
J Nucl Med; 1999 Oct; 40(10):1769. PubMed ID: 10520721
[No Abstract] [Full Text] [Related]
7. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
8. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma.
Lorberboym M; Murthy S; Mechanick JI; Bergman D; Morris JC; Kim CK
J Nucl Med; 1996 Sep; 37(9):1487-91. PubMed ID: 8790199
[TBL] [Abstract][Full Text] [Related]
9. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of patients to detect recurrent thyroid carcinoma.
Grigsby PW; Baglan K; Siegel BA
Cancer; 1999 Feb; 85(4):945-51. PubMed ID: 10091774
[TBL] [Abstract][Full Text] [Related]
11. False-positive findings on (131)I whole-body scans because of posttraumatic superficial scabs.
Regalbuto C; Buscema M; Arena S; Vigneri R; Squatrito S; Pezzino V
J Nucl Med; 2002 Feb; 43(2):207-9. PubMed ID: 11850486
[TBL] [Abstract][Full Text] [Related]
12. Unusual false-positive radioiodine whole-body scans in patients with differentiated thyroid carcinoma.
Salvatori M; Saletnich I; Rufini V; Troncone L
Clin Nucl Med; 1997 Jun; 22(6):380-4. PubMed ID: 9193808
[TBL] [Abstract][Full Text] [Related]
13. [Ovarian endometriosis cyst with iodine 131 uptake : first case of false positive in the follow up for differentiated thyroid carcinoma].
Lungo M; Tenenbaum F; Chaumerliac P; Vons C; Mirat A; Beuzen F; Luton JP; Richard B
Ann Endocrinol (Paris); 2000 May; 61(2):147-50. PubMed ID: 10891665
[TBL] [Abstract][Full Text] [Related]
14. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
[TBL] [Abstract][Full Text] [Related]
15. False-positive 131I whole-body scan in well-differentiated thyroid cancer patient with respiratory bronchiolitis.
Thientunyakit T
Clin Nucl Med; 2013 Sep; 38(9):730-4. PubMed ID: 23510883
[TBL] [Abstract][Full Text] [Related]
16. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma.
Muratet JP; Daver A; Minier JF; Larra F
J Nucl Med; 1998 Sep; 39(9):1546-50. PubMed ID: 9744340
[TBL] [Abstract][Full Text] [Related]
17. Discordant findings of Iodine-131 scintiscan and chest radiogram in carcinoma of thyroid patients.
Rajani AT; Rao PN; Devaru S; Mamathadevi S
Indian J Cancer; 2001; 38(2-4):121-5. PubMed ID: 12593450
[TBL] [Abstract][Full Text] [Related]
18. Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer.
Maxon HR
Q J Nucl Med; 1999 Dec; 43(4):313-23. PubMed ID: 10731782
[TBL] [Abstract][Full Text] [Related]
19. False-positive uptake of I-131 in a laryngocele mimicking thyroid remnant after thyroidectomy for papillary thyroid carcinoma.
Schmidt M; Dietlein M; Schröder U; Schicha H
Clin Nucl Med; 2006 Nov; 31(11):716-7. PubMed ID: 17053394
[TBL] [Abstract][Full Text] [Related]
20. False-positive iodine-131 whole-body scan findings in patients with differentiated thyroid carcinoma: report of 11 cases and review of the literature.
Buton L; Morel O; Gault P; Illouz F; Rodien P; Rohmer V
Ann Endocrinol (Paris); 2013 Jul; 74(3):221-30. PubMed ID: 23796008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]